Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression - A systematic review

Psychiatry Research

Volumn 219, Issue 1, 2014, Pages 25-50

  Baune, Bernhard T ^a   Renger, Lisa ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Antidepressant treatment; Cognitive dysfunction; Cognitive impairment; Cognitive therapy; Depression; Mood disorder; Remediation therapy

Indexed keywords

AMFEBUTAMONE; CAFFEINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DONEPEZIL; DULOXETINE; ESCITALOPRAM; FLUOXETINE; GALANTAMINE; IMIPRAMINE; LORAZEPAM; MAPROTILINE; MOCLOBEMIDE; NORTRIPTYLINE; PAROXETINE; PLACEBO; REBOXETINE; S ADENOSYLMETHIONINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; VILOXAZINE; VORTIOXETINE; ANTIDEPRESSANT AGENT;

ANTIDEPRESSANT ACTIVITY; ATTENTION; CLINICAL TRIAL (TOPIC); COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; CONSTIPATION; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; EMOTIONALITY; EPISODIC MEMORY; FATIGUE; HUMAN; HYPERHIDROSIS; HYPOTENSION; INSOMNIA; MAJOR DEPRESSION; MANIA; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; NAUSEA; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUAL DYSFUNCTION; SHORT TERM MEMORY; SOCIAL STATUS; SOMNOLENCE; STROOP TEST; SUICIDE; SYSTEMATIC REVIEW; TREATMENT RESPONSE; TREMOR; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; VOMITING; XEROSTOMIA; COGNITION DISORDERS; DAILY LIFE ACTIVITY; EXECUTIVE FUNCTION; FEMALE; MEMORY; MIDDLE AGED; PROCEDURES; PSYCHOLOGY;

ACTIVITIES OF DAILY LIVING; ANTIDEPRESSIVE AGENTS; COGNITION; COGNITION DISORDERS; COGNITIVE THERAPY; DEPRESSION; EXECUTIVE FUNCTION; FEMALE; HUMANS; MEMORY; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS;

EID: 84902449150     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.05.013     Document Type: Review

References (87)

1. Allain H., Lieury A., Brunetbourgin F., Mirabaud C., Trebon P., Lecoz F., Gandon J.M. Antidepressants and cognition - comparative effects of moclobemide, viloxazine and maprotiline. Psychopharmacology 1992, 106:S56-S61.
2. Baune B.T., Miller R., McAfoose J., Johnson M., Quirk F., Mitchell D. The role of cognitive impairment in general functioning in major depression. Psychiatry Research 2010, 176:183-189.
3. Baune B.T., Czira M.E., Smith A.L., Mitchell D., Sinnamon G. Neuropsychological performance in a sample of 13-25 year olds with a history of non-psychotic major depressive disorder. Journal of Affective Disorders 2012, 141:441-448.
4. Baune B.T., Li X., Beblo T. Short- and long-term relationships between neurocognitive performance and general function in bipolar disorder. Journal of Clinical and Experimental Neuropsychology 2013.
5. Beblo T., Lautenbacher S. Neuropsychologie der Depression 2006, Hogrefe, Göttingen.
6. Beblo T., Sinnamon G., Baune B.T. Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors. Neuropsychology Review 2011, 21:337-359.
7. Bell M., Bryson G., Greig T., Corcoran C., Wexler B.E. Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance. Archives of General Psychiatry 2001, 58:763-768.
8. Bell M., Bryson G., Wexler B.E. Cognitive remediation of working memory deficits: durability of training effects in severely impaired and less severely impaired schizophrenia. Acta Psychiatrica Scandinavica 2003, 108:101-109.
9. Bondareff W., Alpert M., Friedhoff A.J., Richter E.M., Clary C.M., Batzar E. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. American Journal of Psychiatry 2000, 157:729-736.
10. Booij L., Van der Does A.J.W., Haffmans P.M.J., Riedel W.J., Fekkes D., Blom M.J.B. The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients. Journal of Psychopharmacology 2005, 19:267-275.
11. Bowie C.R., McGurk S.R., Mausbach B., Patterson T.L., Harvey P.D. Combined Cognitive Remediation and Functional Skills Training for Schizophrenia: Effects on Cognition, Functional Competence, and Real-World Behavior. American Journal of Psychiatry 2012, 169:710-718.
12. Burt T., Prudic J., Peyser S., Clark J., Sackeim H.A. Learning and memory in bipolar and unipolar major depression: effects of aging. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 2000, 13:246-253.
13. Butters M.A., Becker J.L., Nebes R.D., Zmuda M.D., Mulsant B.H., Pollock B.G., Reynolds C.F. Changes in cognitive functioning following treatment of late-life depression. American Journal of Psychiatry 2000, 157:1949-1954.
14. Constant E.L., Adam S., Gillain B., Seron X., Bruyer R., Seghers A. Effects of sertraline on depressive symptoms and attentional and executive functions in major depression. Depression and Anxiety 2005, 21:78-89.
15. Culang-Reinlieb M.E., Sneed J.R., Keilp J.G., Roose S.P. Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline. International Journal of Geriatric Psychiatry 2012, 27(8):777-784.
16. Deckersbach T., Nierenberg A.A., Kessler R., Lund H.G., Ametrano R.M., Sachs G., Rauch S.L., Dougherty D. RESEARCH: cognitive rehabilitation for bipolar disorder: an open trial for employed patients with residual depressive symptoms. CNS Neuroscience and Therapeutics 2010, 16:298-307.
17. Docteur A., Mirabel-Sarron C., Guelfi J.D., Rouillon F., Gorwood P. The role of CBT in explicit memory bias in bipolar I patients. Journal of Behavior Therapy and Experimental Psychiatry 2013, 44:307-311.
18. Doraiswamy P.M., Krishnan K.R.R., Oxman T., Jenkyn L.R., Coffey D.J., Burt T., Clary C.M. Does antidepressant therapy improve cognition in elderly depressed patients?. Journals of Gerontology Series A-Biological Sciences and Medical Sciences 2003, 58:1137-1144.
19. Elgamal S., Mckinnon M.C., Ramakrishnan K., Joffe R.T., Macqueen G. Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: a proof of principle study. Psychological Medicine 2007, 37:1229-1238.
20. Fiszdon J.M., Bryson G.J., Wexler B.E., Bell M.D. Durability of cognitive remediation training in schizophrenia: performance on two memory tasks at 6-month and 12-month follow-up. Psychiatry Research 2004, 125:1-7.
21. Fortin M.P., Rouch I., Dauphinot V., Gedeon C., Genthon S., Bonnefoy M., Krolak-Salmon P. Effects of anticholinergic drugs on verbal episodic memory function in the elderly: a retrospective, cross-sectional study. Drugs & Aging 2011, 28:195-204.
22. Fuchs E., Czeh B., Kole M.H., Michaelis T., Lucassen P.J. Alterations of neuroplasticity in depression: the hippocampus and beyond. European Neuropsychopharmacology 2004, 14(Suppl. 5):S481-S490.
23. Gallassi R., Di Sarro R., Morreale A., Amore M. Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy. Journal of Affective Disorders 2006, 91(2-3):243-250.
24. Godard J., Baruch P., Grondin S., Lafleur M.F. Psychosocial and neurocognitive functioning in unipolar and bipolar depression: a 12-month prospective study. Psychiatry Research 2012, 196:145-153.
25. Gorenstein C., de Carvalho S.C., Artes R., Moreno R.A., Marcourakis T. Cognitive performance in depressed patients after chronic use of antidepressants. Psychopharmacology (Berlin) 2006, 185(1):84-92.
26. Han L., McCusker J., Cole M., Capek R., Abrahamowicz M. Antidepressant use and cognitive functioning in older medical patients with major or minor depression-a prospective cohort study with database linkage. Journal of Clinical Psychopharmacology 2011, 4:429-435.
27. Harmer C.J. Antidepressant drug action: a neuropsychological perspective. Depression and Anxiety 2010, 27:231-233.
28. Harmer C.J., Goodwin G.M., Cowen P.J. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. British Journal of Psychiatry 2009, 195:102-108.
29. Harmer C.J., Goodwin G.M., Cowen P.J. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. British Journal of Psychiatry 2009, 195:102-108.
30. Harmer C.J., O'Sullivan U., Favaron E., Massey-Chase R., Ayres R., Reinecke A., Goodwin G.M., Cowen P.J. Effect of acute antidepressant administration on negative affective bias in depressed patients. American Journal of Psychiatry 2009, 166:1178-1184.
31. Heller A.S., Johnstone T., Peterson M.J., Kolden G.G., Kalin N.H., Davidson R.J. Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months. JAMA Psychiatry 2013, 70:1181-1189.
32. Herrara-Guzman I., Gudayol-Ferre E., Herrera-Guzman D., Guardia-Olmos J., Hinojosa-Calvo E., Herrera-Abarca J.E. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. Journal of Psychiatric Research 2009, 43:855-863.
33. Herrera-Guzman I., Gudayol-Ferre E., Lira-Mandujano J., Herrera-Abarca J., Herrera-Guzman D., Montoya-Perez K., Guardia-Olmos J. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder. Psychiatry Research 2008, 160:72-82.
34. Herrera-Guzmán I., Gudayol-Ferré E., Herrera-Guzmán D., Guàrdia-Olmos J., Hinojosa-Calvo E., Herrera-Abarca J.E. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. Journal of Psychiatric Research 2009, 43(9):855-863.
35. Herzallah M.M., Moustafa A.A., Misk A.J., Al-Dweib L.H., Abdelrazeq S.A., Myers C.E., Gluck M.A. Depression impairs learning whereas anticholinergics impair transfer generalization in Parkinson patients tested on dopaminergic medications. Cognitive and Behavioral Neurology 2010, 23:98-105.
36. Herzallah M.M., Moustafa A.A., Natsheh J.Y., Abdellatif S.M., Taha M.B., Tayem Y.I., Sehwail M.A., Amleh I., Petrides G., Myers C.E., Gluck M.A. Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants. Frontiers in Integrative Neuroscience 2013, 7:67.
37. Herzallah M.M., Moustafa A.A., Natsheh J.Y., Abdellatif S.M., Taha M.B., Tayem Y.I., Sehwail M.A., Amleh I., Petrides G., Myers C.E., Gluck M.A. Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants. Frontiers in Integrative Neuroscience 2013, 7:67.
38. Herzallah M.M., Moustafa A.A., Natsheh J.Y., Danoun O.A., Simon J.R., Tayem Y.I., Sehwail M.A., Amleh I., Bannoura I., Petrides G., Myers C.E., Gluck M.A. Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. Journal of Affective Disorders 2013, 151:484-492.
39. Holtzheimer P.E., Meeks T.W., Kelley M.E., Mufti M., Young R., McWhorter K., Vito N., Chismar R., Quinn S., Dey S., Byrd E.H., McDonald W.M. A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression. International Journal of Geriatric Psychiatry 2008, 23:625-631.
40. Jaeger J., Berns S., Uzelac S., Davis-Conway S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Research 2006, 145:39-48.
41. Jorge R.E., Acion L., Moser D., Adams H.P., Robinson R.G. Escitalopram and enhancement of cognitive recovery following stroke. Archives of General Psychiatry 2010, 67:187-196.
42. Katona C., Hansen T., Olsen C.K. A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. International Clinical Psychopharmacology 2012, 27:215-223.
43. Kiosses D.N., Alexopoulos G.S. IADL functions, cognitive deficits, and severity of depression - a preliminary study. American Journal of Geriatric Psychiatry 2005, 13:244-249.
44. Klasik A., Krysta K., Krupka-Matuszczyk I. Effect of tianeptine on cognitive functions in patients with depressive disorders during a 3-month observation. Psychiatria Danubina 2011, 23:S18-S22.
45. Klasik A., Krysta K., Krzystanek M. Impact of psychotherapy and antidepressive treatment on cognitive functions in patients treated for depression. Psychiatria Danubina 2012, 24:S130-S134.
46. Lee R.S.C., Hermens D.F., Porter M.A., Redoblado-Hodge M.A. A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder. Journal of Affective Disorders 2012, 140:113-124.
47. Levkovitz Y., Caftori R., Avital A., Richter-Levin G. The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression. Brain Research Bulletin 2002, 58(4):345-350.
48. Levkovitz Y., Alpert J.E., Brintz C.E., Mischoulon D., Papakostas G.I. Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder. Journal of Affective Disorders 2012, 136:1174-1178.
49. Llado-Pelfort L., Santana N., Ghisi V., Artigas F., Celada P. 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. Cerebral Cortex 2012, 22:1487-1497.
50. Mansell W., Colom F., Scott J. The nature and treatment of depression in bipolar disorder: a review and implications for future psychological investigation. Clinical Psychology Review 2005, 25:1076-1100.
51. Maples N.J., Velligan D.I. Cognitive adaptation: establishing environmental supports to bypass cognitive deficits and improve functional outcomes. American Journal of Psychiatric Rehabilitation 2008, 11:164-180.
52. Martinez-Aran A., Scott J., Colom F., Torrent C., Tabares-Seisdedos R., Daban C., Leboyer M., Henry C., Goodwin G.M., Gonzalez-Pinto A., Cruz N., Sanchez-Moreno J., Vieta E. Treatment nonadherence and neurocognitive impairment in bipolar disorder. Journal of Clinical Psychiatry 2009, 70:1017-1023.
53. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., Silva J.A., McGinnis S., Glass T.G., Martin C.C., Fox P.T. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997, 8:1057-1061.
54. McCabe C., Mishor Z. Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers. Neuroimage 2011, 57:1317-1323.
55. McCabe C., Mishor Z., Cowen P.J., Harmer C.J. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biological Psychiatry 2010, 67:439-445.
56. McIntyre R.S., Cha D.S., Soczynska J.K., Woldeyohannes H.O., Gallaugher L.A., Kudlow P., Alsuwaidan M., Baskaran A. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depression and Anxiety 2013, 30:515-527.
57. Millan M.J., Agid Y., Brune M., Bullmore E.T., Carter C.S., Clayton N.S., Connor R., Davis S., Deakin B., DeRubeis R.J., Dubois B., Geyer M.A., Goodwin G.M., Gorwood P., Jay T.M., Joels M., Mansuy I.M., Meyer-Lindenberg A., Murphy D., Rolls E., Saletu B., Spedding M., Sweeney J., Whittington M., Young L.J. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nature Reviews Drug Discovery 2012, 11:141-168.
58. Mitchell P.B., Wilhelm K., Parker G., Austin M.P., Rutgers P., Malhi G.S. The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. Journal of Clinical Psychiatry 2001, 62:212-216. (quiz 217).
59. Naismith S.L., Redoblado-Hodge M.A., Lewis S.J.G., Scott E.M., Hickie I.B. Cognitive training in affective disorders improves memory: a preliminary study using the NEAR approach. Journal of Affective Disorders 2010, 121:258-262.
60. Nebes R.D., Pollock B.G., Houck P.R., Butters M.A., Mulsant B.H., Zmuda M.D., Reynolds III C.F. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. Journal of Psychiatric Research 2003, 37(2):99-108.
61. Nickel T., Sonntag A., Schill J., Zobel A.W., Ackl N., Brunnauer A., Murck H., Ising M., Yassouridis A., Steiger A., Zihl J., Holsboer F. Clinical and neurobiological effects of tianeptine and paroxetine in major depression. Journal of Clinical Psychopharmacology 2003, 23:155-168.
62. Oakes T.M., Myers A.L., Marangell L.B., Ahl J., Prakash A., Thase M.E., Kornstein S.G. Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol. Human Psychopharmacology 2012, 27(1):47-56.
63. Outhred T., Hawkshead B.E., Wager T.D., Das P., Malhi G.S., Kemp A.H. Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: implications for differential treatment efficacy. Neuroscience and Biobehavioural Reviews 2013, 37:1786-1800.
64. Pearson R.M., O'Mahen H., Burns A., Bennert K., Shepherd C., Baxter H., Chauhan D., Evans J. The normalisation of disrupted attentional processing of infant distress in depressed pregnant women following Cognitive Behavioural Therapy. Journal of Affective Disorders 2013, 145:208-213.
65. Pelton G.H., Harper O.L., Tabert M.H., Sackeim H.A., Scarmeas N., Roose S.P., Devanand D.P. Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. International Journal of Geriatric Psychiatry 2008, 23:670-676.
66. Pringle A., Browning M., Cowen P.J., Harmer C.J. A cognitive neuropsychological model of antidepressant drug action. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:1586-1592.
67. Puig M.V., Santana N., Celada P., Mengod G., Artigas F. in vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cerebral Cortex 2004, 14:1365-1375.
68. Raskin J., Wiltse C.G., Siegal A., Sheikh J., Xu J., Dinkel J.J., Rotz B.T., Mohs R.C. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. American Journal of Psychiatry 2007, 164:900-909.
69. Reinecke A., Waldenmaier L., Cooper M.J., Harmer C.J. Changes in automatic threat processing precede and predict clinical changes with exposure-based cognitive-behavior therapy for panic disorder. Biological Psychiatry 2013, 73:1064-1070.
70. Revheim N., Marcopulos B.A. Group treatment approaches to address cognitive deficits. Psychiatric Rehabilitation Journal 2006, 30:38-45.
71. Robertson I.H., Murre J.M. Rehabilitation of brain damage: brain plasticity and principles of guided recovery. Psychological Bulletin 1999, 125:544-575.
72. Robinson M., Oakes T.M., Raskin J., Liu P., Shoemaker S., Nelson J.C. Acute and long-term treatment of Late-Life Major Depressive Disorder: duloxetine versus placebo. American Journal of Geriatric Psychiatry 2014, 22(1):34-45.
73. Rocca P., Calvarese P., Faggiano F., Marchiaro L., Mathis F., Rivoira E., Taricco B., Bogetto F. Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial. Journal of Clinical Psychiatry 2005, 66:360-369.
74. Roiser J.P., Elliott R., Sahakian B.J. Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 2012, 37:117-136.
75. Sachdev P.S., Valenzuela M. Brain and cognitive reserve. American Association for Geriatric Psychiatry 2009, 17:175-178.
76. Saiz-Ruiz J., Montes J.M., Alvarez E., Cervera S., Giner J., Guerrero J., Seva A., Dourdil F., Lopez-Ibor J.J. Tianeptine therapy for depression in the elderly. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1998, 22:319-329.
77. Savaskan E., Müller S.E., Böhringer A., Schulz A., Schächinger H. Antidepressive therapy with escitalopram improves mood, cognitive symptoms, and identity memory for angry faces in elderly depressed patients. International Journal of Neuropsychopharmacology 2008, 11(3):381-388.
78. Schrijvers D., Maas Y.J., Pier M.P., Madani Y., Hulstijn W., Sabbe B.G. Psychomotor changes in major depressive disorder during sertraline treatment. Neuropsychobiology 2009, 59:34-42.
79. Sharma V.K., Das S., Mondal S., Goswami U., Gandhi A. Effect of Sahaj Yoga on neuro-cognitive functions in patients suffering from major depression. Indian Journal of Physiology and Pharmacology 2006, 50:375-383.
80. Stahl S.M., Lee-Zimmerman C., Cartwright S., Morrissette D.A. Serotonergic drugs for depression and beyond. Current Drug Targets 2013, 14:578-585.
81. Talarowska M., Florkowski A., Zboralski K., Berent D., Wierzbinski P., Galecki P. Auditory-verbal declarative and operating memory among patients suffering from depressive disorders - preliminary study. Advances in Medical Sciences 2010, 55:317-327.
82. Uher R., Maier W., Hauser J., Marusic A., Schmael C., Mors O., Henigsberg N., Souery D., Placentino A., Rietschel M., Zobel A., Dmitrzak-Weglarz M., Petrovic A., Jorgensen L., Kalember P., Giovannini C., Barreto M., Elkin A., Landau S., Farmer A., Aitchison K.J., McGuffin P. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. British Journal of Psychiatry 2009, 194:252-259.
83. Velligan D.I., Prihoda T.J., Ritch J.L., Maples N., Bow-Thomas C.C., Dassori A. A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients. Schizophrenia Bulletin 2002, 28:283-292.
84. WHO Depression: A Global Public Health Concern 2012, World Health Organization, Geneva.
85. Westheide J., Quednow B.B., Kuhn K.U., Hoppe C., Cooper-Mahkorn D., Hawellek B., Eichler P., Maier W., Wagner M. Executive performance of depressed suicide attempters: the role of suicidal ideation. European Archives of Psychiatry and Clinical Neuroscience 2008, 258:414-421.
86. Zimmer M., Duncan A.V., Laitano D., Ferreira E.E., Belmonte-De-Abreu P. A twelve-week randomized controlled study of the cognitive-behavioral Integrated Psychological Therapy program: positive effect on the social functioning of schizophrenic patients. Revista Brasileira De Psiquiatria 2007, 29:140-147.
87. Zobel A., Schulz-Rauschenbach S., von Widdern O.C., Metten M., Freymann N., Grasmader K., Pfeiffer U., Schnell S., Wagner M., Maier W. Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment. Journal of Psychiatric Research 2004, 38(4):377-383.